Stem cell therapy is surrounded by more misinformation than almost any treatment in medicine. Some of it overpromises, some of it scares people away, and most of it misses the actual FDA picture. This article separates the myths from the facts using the FDA's own statements and the current evidence, so you can evaluate any clinic, including ours, with clear eyes.
0
stem cell products FDA-approved for osteoarthritis or any orthopedic condition
2,750
U.S. clinics estimated to be offering unapproved stem cell injections as of 2021
May 2026
when the FDA warned of serious harm, including a reported death, from unapproved cell and tissue products
Stem cell therapy is not illegal. What is unlawful is marketing specific unapproved products as treatments outside of a clinical trial. The FDA has approved blood-forming stem cell products derived from cord blood for certain serious blood disorders, and certain uses of a patient's own cells within the same surgical procedure are allowed. The real question is never whether stem cells are legal, it is whether the specific product a clinic is selling has been approved or studied for what it claims to do.
Almost none do. The treatments marketed by clinics in the United States use adult stem cells, most often from the patient's own bone marrow or fat tissue, or from donated cord blood and related tissues. Embryonic stem cells are a research tool, not what a clinic injects. If a clinic implies its injections come from embryos, that is a red flag, not a selling point.
This is the most dangerous myth of all. Unproven products carry real risks, and the FDA has documented serious adverse events in patients who received unapproved stem cell or exosome products, including bacterial infections, tumors, and blindness. In May 2026 the agency issued a patient and consumer warning about potential serious harm from unapproved products made from human cells or tissues, noting a reported patient death potentially associated with one such product. A treatment can be real and still carry risk, which is exactly why honest clinics discuss risk before they discuss results.
“The FDA's May 2026 patient and consumer warning describes reports of serious harm, including a reported patient death, potentially associated with unapproved products made from human cells or tissues.”
Registration and approval are completely different things. Facilities that handle human cells and tissues register with the FDA, but registration does not mean any product they sell has been reviewed or approved. The vast majority of stem cell products marketed in the United States are unapproved, and an estimated 2,750 clinics were offering unapproved stem cell injections as of 2021. Ask about the product's approval status, not the facility's registration.
The FDA regulates autologous products too. Cells taken from your own body and given back to you can fall under FDA oversight when they are more than minimally manipulated or used for a purpose other than their basic function. That is why the honest conversation is not about whether regulation applies, it is about which category a specific preparation falls into and what that means for the evidence behind it.
A clinic that markets a single stem cell or exosome product for dozens of unrelated conditions, from knee pain to Alzheimer's, is a hallmark of a bad-actor clinic. Serious medicine is condition-specific: the evidence for a knee injection does not transfer to a neurological condition, and a clinic that implies otherwise is not reading the same literature you can read.
Time in the market is not proof of efficacy. Most cell-based and PRP treatments remain investigational for the conditions they are used to treat, and their safety and effectiveness have not been established through the standard FDA pathway. Longevity of a marketing claim and strength of a clinical evidence base are two different things, and only the second one should drive your decision.
The FDA-approved stem cell products in the United States are blood-forming (hematopoietic) stem cells from cord blood, used for certain serious blood and immune disorders. There are no FDA-approved stem cell products for osteoarthritis, joint pain, or any orthopedic condition, and there are no FDA-approved exosome products for any therapeutic use. Any clinic offering cell-based or exosome therapy for joints is working with investigational therapy, and a trustworthy clinic says so plainly.
“Generally, all stem cell products require FDA approval before they can be legally marketed, and the agency continues to receive reports of adverse reactions after unapproved products are used.”
A note from the clinic
At Aloha Stem Cell in Honolulu, our treatments are autologous: cells from your own bone marrow or fat, and platelets from your own blood, prepared in the clinic for same-day use. We are transparent that cell-based treatments are investigational for most conditions, and we will always tell you honestly what the evidence does and does not support. Call (808) 593-2525 or book a consultation to talk it through.
Our team is happy to listen to your story, answer your questions, and help you decide whether a consultation makes sense. There is no pressure and no obligation.
Keep reading
The FDA now lists Regenecyte, a cord blood stem cell product, among approved cellular therapies. It is a real milestone for blood stem cell transplant patients, and it is not a treatment for joint pain. Here is what the approval is, what it is not, and why it matters when you read stem cell news.
In September 2026 the FDA granted Fast Track status to an experimental cell therapy for ALS, and in August researchers presented new Phase 1/2 data on a stem cell therapy for Parkinson's. Both are real advances and both remain investigational. Here is the honest read.
A stem cell-derived islet therapy restored insulin production in early trials, with 10 of 12 patients insulin-independent at one year. Here is what the 2025-2026 results show, what the FDA has and has not done, and what it means for people with diabetes.
Book a consultation
Pick a time that works for you and our team will confirm your consultation. Questions first? Call us anytime at (808) 593-2525.